Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Blombäck's Essential Guide to Blood Coagulation (eBook)

A Practical Guide to Diagnosis and Treatment of Hemostatic Disorders
eBook Download: EPUB
2025 | 3. Auflage
547 Seiten
Wiley (Verlag)
9781394223138 (ISBN)

Lese- und Medienproben

Blombäck's Essential Guide to Blood Coagulation -
Systemvoraussetzungen
61,99 inkl. MwSt
(CHF 59,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

New edition of a concise, comprehensive, easy-to-read pocket book distilling the most clinically up-to-date information on thrombotic and bleeding disorders

In a concise manner, Blombäck's Essential Guide to Blood Coagulation distills the most clinically up-to-date information on thrombotic and bleeding disorders, including the latest treatment strategies for key conditions and diseases. This book covers both the stable and the acute stages of hereditary and acquired bleeding and thrombotic disorders in adults, children, and geriatric patients. It also highlights the laboratory tests that can aid in diagnosing and identifying the cause of bleeding and/or thrombosis in a patient.

The book is organized into four main sections, each featuring numerous updates in this new edition. The first part introduces the reader to laboratory hemostasis and hemostasis physiology. The second part covers bleeding disorders, including a new chapter on bleeding disorders and aging. The third part discusses thromboembolic disorders, with a new chapter on extracorporeal membrane oxygenation (ECMO). The final section addresses special issues in hemostasis, with new chapters on hemostasis in renal disease, liver disorders, and cancer, as well as updated information on thrombotic thrombocytopenic purpura.

This edition of Blombäck's Essential Guide to Blood Coagulation also includes updates on:

  • Hemostasis in COVID-19 and vaccine-induced thrombotic thrombocytopenia (VITT), a rare condition observed during pandemic
  • Critical bleeding in different clinical situations and hemostasis in obstetrics and gynecology
  • Platelet disorders, and rare coagulation factor deficiencies, cerebral vein and splanchnic vein thrombosis
  • The greater paradigm shift in the treatment of hereditary bleeding disorders since the last edition was published
  • Laboratory issues in hemostasis, including nomenclature and sampling
  • Specific issues of hemostasis in children

Compact enough to fit into a coat pocket, Blombäck's Essential Guide to Blood Coagulation is a valuable guide for all those treating patients to expand their knowledge of hemostatic disorders. This text fills a void for the residents, fellow doctors, and practicing physicians who need rapid access to up-to-date information.

Jovan P. Antovic, MD, PhD, Professor in coagulation and clinical chemistry and Senior Consultant, Department of Clinical Chemistry, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Coagulation Research, Karolinska Institutet, Stockholm, Sweden.

Maria Magnusson, MD, PhD, Head of the Department of Hematology and Senior Consultant in pediatric and adult coagulation, Karolinska University Hospital. Affiliated researcher, Department of Molecular Medicine & Surgery and Division of Pediatrics, Department of Clinical Science, Intervention & Technology, Karolinska Institutet.


New edition of a concise, comprehensive, easy-to-read pocket book distilling the most clinically up-to-date information on thrombotic and bleeding disorders In a concise manner, Blomb ck s Essential Guide to Blood Coagulation distills the most clinically up-to-date information on thrombotic and bleeding disorders, including the latest treatment strategies for key conditions and diseases. This book covers both the stable and the acute stages of hereditary and acquired bleeding and thrombotic disorders in adults, children, and geriatric patients. It also highlights the laboratory tests that can aid in diagnosing and identifying the cause of bleeding and/or thrombosis in a patient. The book is organized into four main sections, each featuring numerous updates in this new edition. The first part introduces the reader to laboratory hemostasis and hemostasis physiology. The second part covers bleeding disorders, including a new chapter on bleeding disorders and aging. The third part discusses thromboembolic disorders, with a new chapter on extracorporeal membrane oxygenation (ECMO). The final section addresses special issues in hemostasis, with new chapters on hemostasis in renal disease, liver disorders, and cancer, as well as updated information on thrombotic thrombocytopenic purpura. This edition of Blomb ck s Essential Guide to Blood Coagulation also includes updates on: Hemostasis in COVID-19 and vaccine-induced thrombotic thrombocytopenia (VITT), a rare condition observed during pandemicCritical bleeding in different clinical situations and hemostasis in obstetrics and gynecologyPlatelet disorders, and rare coagulation factor deficiencies, cerebral vein and splanchnic vein thrombosisThe greater paradigm shift in the treatment of hereditary bleeding disorders since the last edition was publishedLaboratory issues in hemostasis, including nomenclature and samplingSpecific issues of hemostasis in children Compact enough to fit into a coat pocket, Blomb ck s Essential Guide to Blood Coagulation is a valuable guide for all those treating patients to expand their knowledge of hemostatic disorders. This text fills a void for the residents, fellow doctors, and practicing physicians who need rapid access to up-to-date information.

Abbreviations


aCL
Cardiolipin antibodies
ACS
Acute coronary syndrome
ACT
Activated clotting time
ADAMTS‐13
A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13
ADP
Adenosine diphosphate
AF
Atrial fibrillation
AFLP
Acute fatty liver of pregnancy
AHA
Acquired hemophilia
AIS
Acute ischemic stroke
AKI
Acute kidney injury
ANCA
Antineutrophil cytoplasmic antibodies
APC
Activated protein C
aPL
Phospholipid antibodies
APS
Antiphospholipid syndrome
APTT
Activated partial thromboplastin time
ARDS
Acute respiratory distress syndrome
ART
Assisted reproductive technology
AS
Ankylosing spondylitis
ASA
Acetylsalicylic acid
ASCVD
Atherosclerotic cardiovascular disease
ASH
American Society of Hematology
ASPI
Aspirin test (Multiplate®)
ATLS
Advanced trauma life support
ATP
Adenosine triphosphate
AVK
Anti‐vitamin K
AVWD
Acquired von Willebrand disease
BAT
Bleeding assessment tool
BCS
Budd–Chiari syndrome
BDUC
Bleeding disorder of unknown cause
BMI
Body mass index
BSS
Bernard–Soulier syndrome
BHV
Bioprosthetic heart valve
BT
Bleeding time
CABG
Coronary artery by‐pass grafting
CAD
Coronary artery disease
CAPS
Catastrophic antiphospholipid syndrome
CAT
Cancer‐associated thrombosis
CBA
Collagen binding assay
CCS
Chronic coronary syndrome
CCT
Conventional coagulation tests
CFC
Coagulation factor concentrate
CKD
Chronic kidney disease
CLIA
Chemiluminescence immunoassay
CNS
Central nervous system
COC
Combined contraceptive pills
COX‐1
Cyclooxygenase‐1
CRP
C‐reactive protein
CSA
Chromogenic substrate assay
CT
Computed tomography
CTA
Computed tomography angiography
CTEPH
Chronic thromboembolic pulmonary hypertension
CTPA
Computed tomography pulmonary angiography
CVB
Chorionic villi biopsy
CVC
Central venous catheter
CVD
Cardiovascular disease
CVT
Cerebral venous thrombosis
DAPT
Dual antiplatelet therapy
DCI
Delayed cerebral ischemia
DDAVP
Deamino D‐arginine vasopressin
DIC
Disseminated intravascular coagulation
DOAC
Direct oral anticoagulants
DTI
Direct thrombin inhibitors
DVT
Deep venous thrombosis
ECCO2ER
Extracorporeal carbon dioxide removal
ECLS
Extracorporeal life support
ECMO
Extracorporeal membrane oxygenation
ECT
Ecarin clotting time
EDA
Epidural anesthesia
EDS
Ehlers–Danlos syndrome
EDTA
Ethylene‐diamine‐tetra‐acetic acid
eGFR
Estimated glomerular filtration rate
EHL
Extended half‐life
EMA
European Medicines Agency
EPCR
Endothelial protein C receptor
ERCP
Endoscopic retrograde cholangiopancreatography
ET
Essential thrombocytemia
ETP
Endogenous thrombin potential
FVIII
Factor VIII
FIX
Factor IX
FDP
Fibrin degradation products
FFP
Fresh frozen plasma
FM
Fibrin monomer
FPA
Fibrinopeptide A
GCA
Giant cell arteritis
GHA
Global hemostatic assays
GI
Gastrointestinal
GT
Glanzmann thrombasthenia
HALT
Hypoattenuated leaflet thickening
HCV
Hepatitis C virus
HDL
High‐density lipoprotein
HELLP
Hemolysis, elevated liver enzymes, low platelet counts
HHT
Hereditary hemorrhagic telangiectasia
HIPA
Heparin‐induced platelet aggregation
HIT
Heparin‐induced thrombocytopenia
HIV
Human immunodeficiency virus
HMB
Heavy menstrual bleeding
HRT
Hormone replacement therapy
HUS
Hemolytic uremic syndrome
ICH
Intracerebral hemorrhage
ICU
Intensive care unit
IFCC
International Federation of Clinical Chemistry and Laboratory Medicine
IHD
Ischemic heart disease
INR
International normalized ratio
IPF
Immature platelet fraction
IS
Ischemic stroke
ISI
International sensitivity index
ISTH
International Society on Thrombosis and Haemostasis
ITI
Immune tolerance induction
ITP
Imunne thrombocytopenia
IU
International unit
IUFD
Intrauterine fetal death
IUPAC
International Union of Pure and Applied Chemistry
IV
Intravenous
IVT
Intravenous thrombolysis
LA
Lupus anticoagulant
LAHPS
Lupus anticoagulant‐hypoprothrombinemia syndrome
LDA
Low‐dose aspirin
LDL
Low‐density lipoprotein
LMWH
Low molecular weight heparin
LTA
Light transmission aggregometry
MAP
Mean arterial pressure
MCFD2
Multiple coagulation factor deficiency genes
MGUS
Monoclonal gammopathy of unknown significance
MHV
Mechanical heart valve
MI
Myocardial infarction
MOF
Multiple organ failure
MPHV
Mechanical prosthetic heart valve
MPV
Mean platelet volume
MRA
Magnetic resonance angiography
MRI
Magnetic resonance imaging
MRT
Magnetic resonance tomography
MRV
Magnetic resonance venography
NETS
Neutrophil extracellular traps
NGS
Next‐generation sequencing
NHF
National Hemophilia Foundation
NHI
National Institute of Health
NOAC
New oral anticoagulant drug
NSAID
Nonsteroidal antiinflammatory drug
NSTEMI
Non ST‐elevation myocardial infarction
OAC
Oral anticoagulants
OC
Oral contraceptives
OCP
Overall coagulation potential
OFP
Overall fibrinolytic potential
OHP
Overall hemostatic potential
OHSS
Ovarian hyperstimulation syndrome
OSA
One‐stage assay
PAD
Peripheral artery disease
PAI‐1
Plasminogen activator inhibitor 1
PAP
Plasmin‐antiplasmin
PBAC
Pictorial blood loss assessment chart
PCC
Prothrombin‐complex concentrate
PCI
Percutaneous coronary intervention
PCR
Polymerase chain reaction
PDW
Platelet distribution width
PE
Pulmonary embolism
PF4
Platelet factor 4
PFT
Platelet function test
PGT
Preimplantation genetic testing
POCT
Point‐of‐care test
PRICE
Protection, Rest, Ice, Compression, and Elevation
Pro‐BNP
Pro B‐type natriuretic protein
PT
Prothrombin time
PTA
Percutaneous transluminal angioplasty
PTM
Platelet transmission electron microscopy
PTS
Post‐thrombotic syndrome
PVT
Portal vein thrombosis
QPD
Quebec platelet disorder
RA
Rheumatoid arthritis
RBC
Red blood cells
REBOA
Resuscitative endovascular balloon occlusion of the aorta
RIPA
Ristocetin‐induced platelet aggregation
ROTEM
Rotational thromboelastometry
rt‐PA
Recombinant tissue plasminogen activator
SAH
Subarachnoid hemorrhage
SAVR
Surgical aortic valve replacement
SC
Subcutaneous
SF
Soluble fibrin
SLE
Systemic lupus erythematosus
SpA
Spondylarthritis
SSc
Systemic sclerosis
SSC
Scientific and Standardization Committee
SSRI
Selective serotonin reuptake inhibitor
STEMI
ST‐elevation myocardial infarction
TAFI
Thrombin activatable fibrinolysis inhibitor
TAR
Thrombocytopenia with absent radius
TAT
Thrombin‐antithrombin
TAVI
Transcatheter valve implantation
TBI
Traumatic brain injury
TDM
Therapeutic drug monitoring
TEG
Thromboelastography
TF
Tissue factor
...

Erscheint lt. Verlag 3.9.2025
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Innere Medizin
Schlagworte acquired bleeding • acute bleeding • bleeding disorders, thrombotic treatment • laboratory hemostasis • stable bleeding • thrombotic diagnosis • thrombotic disorders • thrombotic tests • vaccine-induced thrombotic thrombocytopenia (VITT)
ISBN-13 9781394223138 / 9781394223138
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
EPUBEPUB (Adobe DRM)

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich